x min read

Stocks With Major News: Compass Diversified Holdings (NYSE:CODI), Ebix Inc. (NASDAQ:EBIX), Merck & Co. Inc. (NYSE:MRK)

Stocks With Major News: Compass Diversified Holdings (NYSE:CODI), Ebix Inc. (NASDAQ:EBIX), Merck & Co. Inc. (NYSE:MRK)
Written by
Ryan Mitchell
Published on
November 12, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Compass Diversified Holdings (NYSE:CODI) Trend Analysis reported that it has priced a public offering of 6M trust shares at a price of $17.50 a share. The firm anticipates to receive $105M of gross proceeds from the offering Compass Diversified Holdings (NYSE:CODI) stock has highest price of $17.16 in last session, beginning with a price of $16.86 and reported a decrease of -6.23% to the closed at $17.16 with a day range of $16.70-$17.16. The stock is going forward its 52-week low with 10.17% and moving down from its 52 week high price with -7.64%.Barington Capital Group sends letter to the Chairman and CEO Of Ebix Inc. (NASDAQ:EBIX) Trend Analysis; calls for the addition of new Independent Directors to the Ebix Board. "In the letter, Barington states that it believes that the Company's strong market position and track record of profitable growth is not being recognized by the marketplace. The Company's common stock is currently trading at a low price to earnings ratio that is well below that of the Company's peers and the market as whole. Ebix Inc. (NASDAQ:EBIX) stock hit highest price at $16.74, beginning with a price of $15.95 and reported an increase of 6.86% to the closed at $16.67 with a day range of $15.63-$16.74. The total market capitalization remained 639.0 Million, total volume of 1.04 Million shares held in the session was surprisingly higher than its average volume of 366.86 shares.Merck & Co. Inc. (NYSE:MRK) Trend Analysis released that the presentation of results from a multi-arm Phase 2 clinical test evaluating grazoprevir/elbasvir; first wave of Phase 3 development program for Grazoprevir/Elbasvir is fully enrolled; Merck plans to submit NDA in 2015. Shares of Merck & Co. Inc. (NYSE:MRK) traded at $59.37 by moving up 0.95% with price volatility of 1.49% for a week and 1.97% for a month. Its beta stands at 0.33 times.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You